Journal profile · CARDIAC & CARDIOVASCULAR SYSTEMS
Cardiovascular Intervention and Therapeutics
ISSN 1868-4300 · eISSN 1868-4297 · Springer Nature · 4 issues per year
Cardiovascular Intervention and Therapeutics: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 5.5 (journal website); fully open access; APC about USD 4,090; median 67 days to acceptance (88 articles, last 24 months); 147 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Cardiovascular Intervention and Therapeutics is published by Springer Nature and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Coronary Interventions and Diagnostics, Cardiac Valve Diseases and Treatments and Cardiac Imaging and Diagnostics, together about 40.1% of its articles. Its main subfields are Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine. (generated from OpenAlex topic counts and CAS ranking data)
Cardiovascular Intervention and Therapeutics (CVIT) is an international journal covering the field of cardiovascular disease and includes cardiac (coronary and noncoronary) and peripheral interventions and therapeutics. Articles are subject to peer review and complete editorial evaluation prior to any decision regarding acceptability. CVIT is an official journal of The Japanese Association of Cardiovascular Intervention and Therapeutics.
From the journal's Aims & Scope
Research area (LetPub): CARDIAC & CARDIOVASCULAR SYSTEMS
Editor-in-chief Yoshio KobayashiPublisher website
Editorial board by country: 1 in mainland China (about 1%); most named Japan 92, United States 6, South Korea 3, Taiwan, China 2, Denmark 2 (112 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Coronary Interventions and DiagnosticsMedicine18.8%
- Cardiac Valve Diseases and TreatmentsMedicine11.3%
- Cardiac Imaging and DiagnosticsMedicine9.9%
- Peripheral Artery Disease ManagementMedicine7%
- Vascular Procedures and ComplicationsMedicine6.7%
- Acute Myocardial Infarction ResearchMedicine6%
- Infective Endocarditis Diagnosis and ManagementMedicine4.4%
- Cerebrovascular and Carotid Artery DiseasesMedicine3.5%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Cardiac & Cardiovascular Systems | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Cardiac & Cardiovascular Systems | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEEmbaseCASPublisher website
Other: Google Scholar, EBSCO, ProQuest, Dimensions, CNKI, Baidu, Naver, OCLC, Portico, CLOCKSS, Semantic Scholar
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher) 2025
- 5.5Publisher website ·
- 5-year impact factor (publisher) 2025
- 3.6Publisher website ·
- CiteScore 2026-06
- 4.4LetPub ·
- SJR 2026-06
- 0.65LetPub ·
- SNIP 2026-06
- 1.32LetPub ·
- h-index
- 39OpenAlex ·
- i10-index
- 300OpenAlex ·
- 2-year mean citedness
- 2.75OpenAlex ·
- Self-citation rate
- 9.1%LetPub ·
- Share of gold OA articles
- 32.11%LetPub ·
Volume
- Articles per year
- 100LetPub ·
- Downloads per year (publisher) 2025
- 291,600Publisher website ·
Articles by year OpenAlex count · 1,363 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 122 | 52 | 37 |
| 2025 | 147 | 52 | 345 |
| 2024 | 104 | 24 | 643 |
| 2023 | 72 | 20 | 636 |
| 2022 | 73 | 21 | 836 |
| 2021 | 93 | 30 | 700 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
67 daysMedian, submission to acceptance · P25–P75 47 days – 105 days
- Acceptance to online
- median 17 days (88 articles)
- Submission to online
- median 87 days
- Sample
- 88 articles with submission and acceptance dates (301 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Submission to first decision
- 4 daysPublisher website ·
- Peer review
- Single-anonymous peer reviewPublisher website · model-extracted
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessLetPub
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 4,090 / EUR 3,090 / GBP 2,690 | — | — |
Other charges and waivers (author guidelines)
- Other fees
- No other fees
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare5 items from the author guidelines
- Abstract
- ≤ 250 words
- Keywords
- 3–5
- Manuscript length
- ≤ 6,000 words
- Reference style
- Numbered, in order of citation
- Cover letter
- Required
Article types accepted6, with length limits
- images in cardiovascular interventionImages in Cardiovascular Intervention, not to exceed 500 words including Title, Text, References, Figure legends and Acknowledgements. In the Text, no abstract …Length not stated
- invited review articlesInvited review articles, usually not to exceed 8000 words, although exceptions may be made by the Editors.Length not stated
- original articles articles in the following categories: Original articles, not to exceed 6000 words including Title, Abstract, Text, References, Figure legendsmain text ≤ 6,000 words
- original articlesOriginal articles, not to exceed 6000 words including Title, Abstract, Text, References, Figure legends, Tables and Acknowledgments.Length not stated
- reviewAll manuscripts will be reviewed first by the Editorial Committee. All papers considered suitable by the Editors to progress further in the review process will …Length not stated
- review articled be no more than 3 references. Invited review articles, usually not to exceed 8000 words, although exceptions may be made by the Editors. Back to tomain text ≤ 8,000 words
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Data availability, Publication ethics, License & copyright, Open access, Peer review, Preprints, Trial registration / reporting guidelines
- AI use Generative AI Images
Please check Springer’s policy on generative AI images and make sure your work adheres to the principles described therein. Back to top
Source ↗Publisher website ·- Authorship Authorship cover letter
An author's cover letter is required for submission. Please state in the cover letter that “This is an original manuscript and has not been previously published or submitted to another journal.” Back to top
Source ↗Publisher website ·- Conflicts of interest Disclosures and declarations
All authors are requested to include information regarding sources of funding, financial or non-financial interests, study-specific approval by the appropriate ethics committee for research involving humans and/or animals, informed consent if the research involved human participants, and a statement on welfare of animals if the research involved animals (as appropriate). The decision whether such …
Source ↗Publisher website ·- Data availability
Data transparency Model summary
All authors are requested to make sure that all data and materials as well as software application or custom code support their published claims and comply with field standards. Please note that journals may have individual policies on (sharing) research data in concordance with disciplinary norms and expectations.
Source ↗Publisher website ·- Publication ethics
Ethical Responsibilities of Authors Model summary
This journal is committed to upholding the integrity of the scientific record. As a member of the Committee on Publication Ethics (COPE) the journal will follow the COPE guidelines on how to deal with potential acts of misconduct.
Source ↗Publisher website ·- License & copyright Copyright transfer
Permissions Model summary
Authors will be asked to transfer copyright of the article to the CVIT. This will ensure the widest possible protection and dissemination of information under copyright laws. Back to top
Source ↗Publisher website ·- Open access Open access publishing
To find out more about publishing your work Open Access in Cardiovascular Intervention and Therapeutics, including information on fees, funding and licences, visit our Open access publishing page. Back to top
Source ↗Publisher website ·- Peer review
Review of manuscripts Model summary
All manuscripts will be reviewed first by the Editorial Committee. All papers considered suitable by the Editors to progress further in the review process will undergo appropriate peer review.When a manuscript is returned to the author for revision, it should be returned within 3 months.
Source ↗Publisher website ·- Preprints
Exclusive submission policy Model summary
Manuscripts are considered for review only under the conditions that they are not under consideration elsewhere and that the data presented have not appeared on the Internet or have not been previously published with the exception of abstracts not exceeding 400 words.
Source ↗Publisher website ·- Trial registration / reporting guidelines Clinical Trial Registration
The World Health Organization (WHO) definition of a clinical trial is "any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes". The WHO defines health interventions as “A health intervention is an act performed for, with or on behalf of a person or population whose purpose is to ass…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Springer Nature
- Frequency
- 4 issues per year
- ISSN
- 1868-4300
- Electronic ISSN
- 1868-4297
- Society / sponsor
- Japanese Society for Interventional Cardiology
- Latest issue on the website
- Volume 41, Issue 3 (July 2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
- Author guidelines ↗LetPub
FAQ
Frequently asked questions about Cardiovascular Intervention and Therapeutics
What CAS zone is Cardiovascular Intervention and Therapeutics in?
In the 2025 upgraded edition of the CAS Journal Ranking, Cardiovascular Intervention and Therapeutics is in Zone 3 of Medicine, and in Zone 3 of the minor category Cardiac & Cardiovascular Systems. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Cardiovascular Intervention and Therapeutics?
The journal's website gives an impact factor of 5.5 (2025); this is the journal's own figure, as LetPub lists none for it; CiteScore 4.4, h-index 39.
How long does peer review take at Cardiovascular Intervention and Therapeutics?
Based on the dates recorded on 88 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 67 days (interquartile range 47–105 days). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Cardiovascular Intervention and Therapeutics?
According to the journal's author guidelines: Abstract: ≤ 250 words; Keywords: 3–5; Manuscript length: ≤ 6,000 words; Reference style: Numbered, in order of citation; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Cardiovascular Intervention and Therapeutics based?
Of the 112 board members whose country the journal's board page names, 1 (about 1%) are in mainland China; the countries named most often are Japan (92), United States (6) and South Korea (3). Counted from the institutions listed on the board page; for reference only.
Which databases index Cardiovascular Intervention and Therapeutics?
According to LetPub and DOAJ records, Cardiovascular Intervention and Therapeutics is indexed in ESCI and Scopus. The journal's website also lists MEDLINE, Embase and CAS; that list has not been checked against each database.
Is Cardiovascular Intervention and Therapeutics open access, and what is the APC?
Cardiovascular Intervention and Therapeutics is a fully open-access journal. APC about USD 4,090.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .